Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy

Exclusion Criteria

• •Use of any pharmacologic treatment (other than corticosteroids) within 12 weeks that may have an effect on muscle strength or function (e.g., growth hormone, anabolic steroids).
• •Previous or current treatment with any other experimental treatments within 12 weeks or participation in any other clinical trial within 6 months.
• •Major surgery within 3 months prior to the first dose of study drug, or planned surgery during this study which would interfere with the ability to perform study activities.
• •Presence of other clinically significant illness.